Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trulieve CannabisFRA:F09 +16.84%65 Cash Ratio is 3.42 as of Jun. 2026, which is 128% above its 10-year median of 1.50. GuruFocus rates FRA:F09 with a GF Score™ of 65/100 and a GF Value™ of €5.96 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 961 Drug Manufacturers companies, Trulieve Cannabis ranks better than 87.72% on this metric.
Trulieve Cannabis has a Cash Ratio of 3.42. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Trulieve Cannabis's Cash Ratio or its related term are showing as below:
FRA:F09'
s Cash Ratio Range Over the Past 10 Years
Min: 0.11 Med: 1.5 Max: 3.77
Current: 3.42
During the past 10 years, Trulieve Cannabis's highest Cash Ratio was 3.77. The lowest was 0.11. And the median was 1.50.
FRA:F09's Cash Ratio is ranked better than 87.72% of 961
companies
in the Drug Manufacturers industry
Industry Median: 0.6
vs FRA:F09: 3.42
Trulieve Cannabis (FRA:F09) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Trulieve Cannabis Cash Ratio Related Terms
Trulieve Cannabis Cash Ratio Historical Data
* Premium members only.
The historical data trend for Trulieve Cannabis's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:F09 vs ANIP, XERS, HROW: Cash Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trulieve Cannabis Cash Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Trulieve Cannabis's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trulieve Cannabis (FRA:F09) has a Cash Ratio of 3.42 as of Jun. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Trulieve Cannabis and its competitors. This is 128% above median its historical median of 1.50. Over the past decade, Trulieve Cannabis' Cash Ratio has ranged from 0.11 to 3.77. According to the industry distribution chart, Trulieve Cannabis ranks #118 out of 961 companies in the Drug Manufacturers industry, placing it in the top 12.3%.
Is Trulieve Cannabis' Cash Ratio too high?
Trulieve Cannabis' current Cash Ratio of 3.42 is 128% above median its 10-year median of 1.50. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 3.77. The Drug Manufacturers industry median Cash Ratio is 0.60. Trulieve Cannabis' value of 3.42 is 470% above this industry median. Based on the distribution chart, Trulieve Cannabis ranks #118 out of 961 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Trulieve Cannabis has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Trulieve Cannabis' Cash Ratio compare to ANIP and XERS?
According to the Drug Manufacturers industry distribution chart, Trulieve Cannabis ranks #118 out of 961 companies for Cash Ratio. This places Trulieve Cannabis in the top 12% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.60. Trulieve Cannabis' value of 3.42 is 470% above this benchmark. Historically, Trulieve Cannabis' own Cash Ratio has ranged from 0.11 to 3.77 over the past decade. While the company's 10-year median is 1.50 vs. the industry median of 0.60, Trulieve Cannabis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.60, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trulieve Cannabis's current Cash Ratio of 3.42 is 470% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Trulieve Cannabis and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trulieve Cannabis's current Cash Ratio is 3.42, which is 128% above median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trulieve Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Trulieve Cannabis (FRA:F09) is currently considered Significantly Overvalued. The stock's GF Value™ is €5.96, compared to a current price of €9.03 — trading 51.5% above its estimated fair value. The current Cash Ratio is 3.42, which is 128% above median its 10-year median of 1.50 and 470% above the Drug Manufacturers industry median of 0.60. Trulieve Cannabis' overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Trulieve Cannabis (FRA:F09), the current Cash Ratio is 3.42 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trulieve Cannabis (FRA:F09) Overvalued in 2026?
Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued.
The current stock price of €9.03 is trading 51.5% above its estimated GF Value™ of €5.96.
GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.
Key valuation signals for FRA:F09:
Cash Ratio: 3.42 (128% above median its 10-year median of 1.50)
GF Value™: €5.96 vs. price of €9.03 (51.5% above fair value)
Industry Position: 470% above the Drug Manufacturers median (#118 of 961)
No single metric tells the full story. See the FRA:F09 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
65GF Score
Get the complete analysis for FRA:F09
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:F09 has been successfully added to your 
